Biogen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BIIB Nasdaq 2836 www.biogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biogen Inc.

Should Biogen’s (BIIB) New SMA Breakthrough and Lupus Data Prompt a Fresh Look From Investors? - Jun 5th, 2026 2:04 pm
A Look At Biogen (BIIB) Valuation After New Breakthrough SMA Nod And Positive Lupus Phase 3 Data - Jun 5th, 2026 1:12 pm
BIIB's Next-Gen SMA Therapy Salanersen Wins FDA's Breakthrough Tag - Jun 5th, 2026 10:04 am
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? - Jun 4th, 2026 9:30 am
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy - Jun 4th, 2026 5:30 am
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus - Jun 3rd, 2026 11:00 pm
Ocugen's Gene-Agnostic Eye Therapies Could Reshape Late-Stage Care - Jun 3rd, 2026 9:50 am
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses - Jun 3rd, 2026 5:30 am
Getting Alzheimer’s Drugs Into the Brain Is Hard. Now There’s a New Trick. - Jun 3rd, 2026 1:30 am
Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors - Jun 3rd, 2026 1:15 am
Biogen Ends BIIB122 Parkinsons Trial And Refocuses Neurodegeneration Pipeline - Jun 2nd, 2026 4:07 am
Is COMPASS Pathways (CMPS) Quietly Recalibrating Its Commercialization Strategy With This Board Appointment? - Jun 2nd, 2026 3:13 am
Sobi to present new data on pegcetacoplan at ERA 2026 - Jun 1st, 2026 2:19 am
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus - May 31st, 2026 11:30 pm
Why Is Biogen (BIIB) Up 3.8% Since Last Earnings Report? - May 29th, 2026 9:30 am
Ionis Pharmaceuticals Eyes Big Year With TRYNGOLZA Decision, 5 Phase 3 Readouts - May 25th, 2026 6:06 pm
MarketBeat Week in Review – 05/18 - 05/22 - May 23rd, 2026 5:00 am
Biogen Faces Trial Setbacks And Probes That Reframe Neuro Pipeline Risks - May 22nd, 2026 2:15 pm
Denali Stock Dips as Biogen-Partnered Parkinson's Disease Study Fails - May 22nd, 2026 10:14 am
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish - May 22nd, 2026 5:50 am